CAXTON ASSOCIATES LP - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 154 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2019. The put-call ratio across all filers is 2.97 and the average weighting 0.2%.

Quarter-by-quarter ownership
CAXTON ASSOCIATES LP ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q1 2023$180,361
-10.9%
286,287
-8.2%
0.03%
+92.9%
Q4 2022$202,502
-62.3%
311,9740.0%0.01%
-80.6%
Q3 2022$537,000
+329.6%
311,974
+209.8%
0.07%
+500.0%
Q2 2022$125,000
+35.9%
100,715
-28.7%
0.01%
+71.4%
Q1 2022$92,000
-40.3%
141,2540.0%0.01%
-56.2%
Q4 2021$154,000
+18.5%
141,254
+413.5%
0.02%
-11.1%
Q4 2019$130,00027,5060.02%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q4 2019
NameSharesValueWeighting ↓
DISCOVERY CAPITAL MANAGEMENT, LLC / CT 15,461,829$2,037,8690.36%
MSD Partners, L.P. 15,151,516$1,996,9700.16%
MSD Partners, L.P. 7,575,758$998,4850.08%
MAGNOLIA CAPITAL ADVISORS LLC 865,938$65,5520.03%
Allred Capital Management, LLC 253,000$33,3450.02%
CHIRON CAPITAL MANAGEMENT, LLC 77,023$10,1520.01%
Boxer Capital, LLC 1,100,000$144,9800.01%
GSA CAPITAL PARTNERS LLP 569,566$750.01%
Sugarloaf Wealth Management, LLC 75,500$9,9510.00%
Owen LaRue, LLC 11,825$1,5590.00%
View complete list of ZIOPHARM ONCOLOGY INC shareholders